FDA rejection

Gilead
Pharma

Gilead's once-rejected hepatitis D med wins FDA nod

More than three years after Gilead's hepatitis D drug was rebuffed by the FDA on manufacturing concerns, the treatment has redeemed itself.
Fraiser Kansteiner May 26, 2026 9:49am
rejected document

Citizen petition calls on FDA to tighten up CRL disclosures

Apr 23, 2026 11:26am
reducing people on team
Favicon Fierce Biotech

Shedding 60% of workforce, Replimune vows to continue operations

Apr 21, 2026 2:15am
dart board miss failure
Favicon Fierce Biotech

Replimune to lay off staff after 'disappointing' second rejection

Apr 10, 2026 1:56pm
big wave over ship in storm
Favicon Fierce Biotech

Disc lays off 20% of workforce in wake of FDA rejection

Mar 3, 2026 10:45am
Union Square in San Francisco during JPM 2026
Favicon Fierce Biotech

JPM26: Sanofi looks ahead to lingering US policy hurdles

Jan 14, 2026 2:28pm